GPS
57
-3
GE
65
-2
CMA
39
3
HSIC
44
4
AIZ
64
-2
EQIX
50
3
BMY
43
8
AA
38
3
ADT
55
25
FTI
76
2
COST
69
-4
DO
45
2
MCD
46
4
ZTS
49
20
ACN
65
4
FLR
36
-3
EFX
55
-2
KHC
29
2
EQT
19
-5
CAG
39
5
GPS
57
-3
GE
65
-2
CMA
39
3
HSIC
44
4
AIZ
64
-2
EQIX
50
3
BMY
43
8
AA
38
3
ADT
55
25
FTI
76
2
COST
69
-4
DO
45
2
MCD
46
4
ZTS
49
20
ACN
65
4
FLR
36
-3
EFX
55
-2
KHC
29
2
EQT
19
-5
CAG
39
5
Financhill
Back

Sonnet BioTherapeutics Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
1

SONN
Sonnet BioTherapeutics Holdings

Last Price:
0.96
Seasonality Move:
-25.59%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
1
Sonnet BioTherapeutics Holdings (SONN) is a Sell

Is Sonnet BioTherapeutics Holdings a Buy, Sell or Hold?

  • The current Sonnet BioTherapeutics Holdings [SONN] share price is $0.98. The Score for SONN is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • SONN is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SONN Stock Price Chart

What is Sonnet BioTherapeutics Holdings's stock price today?

  • The Sonnet BioTherapeutics Holdings share price today is $0.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SONN is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SONN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 25.53 Sell
Chaikin Money Flow: 28107 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.42 - 1.84) Sell
Bollinger Bands (100): (1.55 - 1.97) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

SONN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.51 Sell
20-day SMA: 1.6 Sell
50-day SMA: 1.72 Sell
200-day SMA: 1.87 Sell
8-day EMA: 1.4 Sell
20-day EMA: 1.57 Sell
50-day EMA: 1.68 Sell
200-day EMA: 4.73 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Sonnet BioTherapeutics Holdings Earnings Growth & SONN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.04 per share, and a decrease next year of $0.38 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Sonnet BioTherapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):